Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?

被引：1
作者：
Zurkan, Daniela [1 ,2 ,3 ,4 ,5 ]
Pitt, Bertram [6 ]
Edelmann, Frank [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Deutsch Herzzentrum Charite, Dept Cardiol, Angiol & Intens Care Med, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany
[3] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany
[4] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany
[5] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany
[6] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 10期
关键词：
KIDNEY-DISEASE; SPIRONOLACTONE; FINERENONE; SURVIVAL;
D O I：
10.1093/eurheartj/ehae040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 777
页数：3
相关论文
共 50 条
  • [21] The Effect of Mineralocorticoid Receptor Antagonists on Recruitment and Function of Endothelial Progenitor Cells in Patients with Congestive Heart Failure
    Levi, Amos
    Leshem-Lev, Dorit
    Weissler-Snir, Adaya
    Hasin, Tal
    Mats, Israel
    Murninkas, Daniel
    Kornowski, Ran
    Lev, Eli I.
    Ben-Gal, Tuvia
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2018, 20 (04): : 233 - 238
  • [22] Determinants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fraction
    Dankowski, Rafal
    Kotwice, Tomasz
    Szyszka, Andrzej
    Przewlocka-Kosmala, Monika
    Sacharczuk, Wioletta
    Karolko, Bozena
    Kobusiak-Prokopowicz, Malgorzata
    Mysiak, Andrzej
    Kosmala, Wojciech
    [J]. KARDIOLOGIA POLSKA, 2018, 76 (09) : 1327 - 1335
  • [23] Patient selection for mineralocorticoid receptor antagonists in heart failure with mildly reduced or preserved ejection fraction
    Vardeny, Orly
    Houle, Hailee
    [J]. PHARMACOTHERAPY, 2023, 43 (06): : 563 - 569
  • [24] Expanding Role of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure
    Talatinian, Alidz
    Chow, Sheryl L.
    Heywood, J. Thomas
    [J]. PHARMACOTHERAPY, 2012, 32 (09): : 827 - 837
  • [25] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    [J]. NATURE REVIEWS CARDIOLOGY, 2023,
  • [26] Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
    Tereshchenko, S. N.
    Zhirov, I. V.
    Osmolovskaya, Yu F.
    [J]. TERAPEVTICHESKII ARKHIV, 2013, 85 (12) : 137 - 143
  • [27] Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
    Henrysson, Josefin
    Thunstrom, Erik
    Chen, Xiaojing
    Fu, Michael
    Basic, Carmen
    [J]. ESC HEART FAILURE, 2023, 10 (01): : 66 - 79
  • [28] Non-steroidal mineralocorticoid receptor antagonists in heart failure
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    [J]. NATURE REVIEWS CARDIOLOGY, 2023, 20 (10) : 645 - 646
  • [29] Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population
    Jonsson, Anna
    Norberg, Helena
    Bergdahl, Ellinor
    Lindmark, Krister
    [J]. CARDIOVASCULAR THERAPEUTICS, 2018, 36 (05)
  • [30] Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis
    Adji, Arga Setyo
    Widjaja, Jordan Steven
    de Liyis, Bryan Gervais
    [J]. EGYPTIAN HEART JOURNAL, 2024, 76 (01)
12345